Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Non-Current Deffered Revenue (2018)

International Stem Cell (ISCO) has disclosed Non-Current Deffered Revenue for 1 consecutive years, with $182000.0 as the latest value for Q4 2018.

  • On a quarterly basis, Non-Current Deffered Revenue changed N/A to $182000.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $182000.0, a N/A change, with the full-year FY2018 number at $182000.0, changed N/A from a year prior.
  • Non-Current Deffered Revenue was $182000.0 for Q4 2018 at International Stem Cell.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $182000.0 in Q4 2018 to a low of $182000.0 in Q4 2018.